DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 496 participants.

Also called NCT07229248

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 496 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07229248
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07229248. Randomized; single masking; primary purpose treatment. Start 2025-11-05 (anticipated); primary completion 2027-12-17 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial
Acronym
DCB-STEMI
Condition
STEMI (ST Elevation MI)
Intervention (Device)
Drug coated balloon (Prevail; Medtronic Inc.)
Intervention (Device)
Drug eluting stent
Lead sponsor
National Institute of Cardiovascular Diseases, Pakistan (class: other)

Record details

Record id
cardio:ct-nct07229248
Content hash
8bfca05b76c8cb1af9f7d0f23437894dfb724192702a1cc2d6ef041b5e66055b